Datamonitor's Onyx Pharmaceuticals, Inc.
- SWOT Analysis Company Profile is the essential source for top-level company data and information.
The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Onyx Pharmaceuticals is a biopharmaceutical company, which discovers and develops therapeutics that target the molecular mechanisms that cause cancer.
It is developing small molecule, orally available drugs with the aim of changing the way cancer is treated.
The company is headquartered in Richmond, California and employs around 125 people.
For the fiscal year ended December 2006, Onyx generated revenues of $0.25 million, a decrease of 75% over 2005.
The operating loss of the company was $105 million during fiscal year 2006, a further decrease of 2.8% over 2005.
The net loss in fiscal year 2006 was $93 million, an improvement of 2.6% over 2005.Scope of the Report- Provides all the crucial company information required for business and competitor intelligence needs- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statementReasons to Purchase- Support sales activities by understanding your customers’ businesses better- Qualify prospective partners and suppliers- Keep fully up to date on your competitors’ business structure, strategy and prospects- Obtain the most up to date company information available